References.
1. Walter, Israel, “Patologia Generale”, Ed. Grasso, Milano, 363-370, (1991).
2. James O’D Mc Gee, Peter G. Isaacson, Nicholas A. Wright, “Patologia I. I principi”, Ed. Zanichelli, 723-725, (1994).
3. Alan Stevens, James Lowe, “Patologia”, Ed. Ambrosiano, 35-48, (1997).
4. Van Der Geer, P.; Hunter, T.; Lindberg, R.A. Receptor proteine kinases and their signal transduction pathways. Annu. Rev. Cell. Biol., 1994, 10, 251- 337.
5. Ullrich, A.; Schlessinger, J. Signal transduction by receptors with tyrosine kinase activity. Cell, 1990, 61, 203-212.
6. G. Vlahovic, J. Crawford, “Activation of Tyrosine Kinases in Cancer”, The Oncologist 2003, 8, 531-538.
7. P. Blume-Jensen, T. Hunter “Oncogenic kinase signalling” Nature 2001, 411, 355-365.
8. G.M. Pontieri, M. A. Russo, L. Frati, Chapter 22, “Oncogeni”: 585-616, Patologia Generale 2008, 3th Edition., PICCIN.
9. S. Trumpp-Kallmeyer, J. R. Rubin, C. Humblet, J.M. Hamby, H.D.H.
Showalter, “Development of Binding Model to Protein Tyrosine Kinases for Substituted Pyrido[2,3-d]pyrimidine Inhibitors”, Journal of Medicinal Chemistry, 1998, 41, 1752-1763.
10. Kerbel, R.S. Carcinogenesis, 2000, 21, 501.
11. B.D. Palmer, S. Trumpp-Kallmeyer, D.W. Fry, J.M. Nelson, H.D.H.
Showalter, W.A. Denny, Tyrosine kinase inhibitors.11. Soluble Analogues of Pyrrolo and Pyrazoloquinazolines as Epidermal Growth Factor Receptor Inhibitors: Synthesis, Biological Evaluation and Modeling of the mode of binding, Journal of Medicinal Chemistry, 1997, 40, 1519-1529.
12. N. Ferrara, “Role of vascular endothelial growth factor in regulation of physiological angiogenesis”, Am. J. Physiol. Cell Physiol. 2001, 280, 1358- 1366.
Rosen, L.S. Cancer Control., 2002, 9, 36.
15. Leung, D.W.; Cachianes, D.; Kuang, W.J.; Goeddel, D.V.; Ferrara, N.
Science,1989, 246, 1306.
16. Shibuya, M.; Yamaguchi, S.; Yamane, A.; Ikeda, T.; Tojo, A.; Matsushime, H.; Sato, M. Oncogene, 1990, 5, 519.
17. Matthews, W.; Jordan, C.T.; Gavin, M.; Jenkins, N.A.; Copeland, N.G.;
Lemischka, I.R. Proc. Natl. Acad. Sci. USA, 1991, 88, 9026.
18. Paavonen, K.; Puolakkainen, P.; Jussila, L.; Jahkola, T.; Alitalo, K. Am. J.
Pathol., 2000, 156, 1499.
19. G.D. Yancopoulos, S. Davis, N.W. Gale, J.S. Rudge, S.J. Wiegand, J.
Holash, “Vascular-specific growth factors and blood vessel formation”, Nature 2000, 407, 242-248.
20. C. Wheeler, T. Stephens, K Byth, T. Green, S. Wedge, D. Blakey, A.
Hughes, “Novel approaches in oncology at AstraZeneca”, EJC Supplements 2003, 1, 3-8.
21. B. Frederick, D. Gustafson, C. Bianco, F. Ciardiello, I. Dimery, D. Raben
“ZD6474, An inhibitor of VEGFR and EGFR tyrosine kinase activity in combination with radiotherapy”, International Journal of Radiation Oncology- Biology-Physics 2006, 64, 33–37.
22. A. Vulpetti, R. Bosotti, Sequence and structural analysis of kinase ATP pocket residues, Il Farmaco, 2004, 59, 759-765.
23. Hanahan, D.; Folkman, J. Cell, 1996, 86, 353.
24. Rahimi, N. Front. Biosci., 2006, 11, 818.
25. Jain, R.K. Nat. Med., 2001, 7, 987.
26. Gasparrini, G. Drugs, 1999, 58, 17.
27. Carmeliet, P.; Moons, L.; Luttun, A.; Vincenti, V.; Compernolle, V.;
DeMol, M.; Wu, Y.; Bono, F.; Devy, L.; Beck, H.; Scholz, D.; Acker, T.; Di Palma, T.; Dewerchin, M.; Noel, A.; Stalmans, I.; Barra, A.; Blacher, S.;
Vandendriessche, T.; Ponten, A.; Eriksson, U.; Plate, K.H.; Foidart, J.M.;
Schaper, W.; Charnock-Jones, D.S.; Hicklin, D.J.; Herbert, J.M.; Collen, D.;
Persico, M.G. Nat. Med., 2001, 7, 575.
28. Zhao, Q.; Egashira, K.; Hiasa, K.; Ishibashi, M.; Inoue, S.; Ohtani, K.; Tan, C.; Shibuya, M.; Takeshita, A.; Sunagawa, K. Arterioscler. Thromb. Vasc.
Biol., 2004, 24, 2284.
29. Sharma, P. S.; Sharma, R.; Tyagi, T. VEGF/VEGFR pathway Inhibitors as Anti-Angiogenic Agents: Present and Future. Current Cancer Drug Targets, 2011, 11, 624-653.
30. Ferrara, N. Oncology, 2005, 69, 11.
31. Ferrara, N.; Hillan, K.J.; Novotny, W. Biochem. Biophys. Res. Commun., 2005, 333, 328.
32. Ferrara, N.; Damico, L.; Shams, N.; Lowman, H.; Kim, R. Retina, 2006, 26, 859.
33. Lee, J.H.; Canny, M.D.; De Erkenez, A.; Krilleke, D.; Ng, Y.S.; Shima, D.T.; Pardi, A.; Jucker, F. Proc. Natl. Acad. Sci. USA, 2005, 102, 18902.
34. Weng, D.E.; Usman, N. Curr. Oncol. Rep., 2001, 3, 141.
35. Weng, D.E.; Masci, P.A.; Radka, S.F.; Jackson, T.E.; Weiss, P.A.;
Ganapathi, R.; Elson, P.J.; Capra, W.; Parker, V.P.; Lockridge, J.A.;
Cowens, J.W.; Usman, N.; Borden, E.C. Mol. Cancer Ther., 2005, 4, 948.
36. Konner, J.; Dupont, J. Clin. Colorectal Cancer, 2004, (Suppl 2), S81.
37. Nguyen, Q.D.; Shah, S.M.; Hafiz, G.; Quinlan, E.; Sung, J.; Chu, K.;
Cedarbaum, J.M.; Campochiaro, P.A. Ophthalmology, 2006, 113, 1522.
38. T.L. Underiner, B. Ruggeri and D.E. Gingrich, “Development of Vascular Endothelial Growth Factor Receptor (VEGFR) Kinase Inhibitors as Anti- Angiogenic Agents in Cancer Therapy”, Current Medicinal Chemistry, 2004, 11, 731-745.
39. G. Bold et al. “New Anilino Phthalazines as Potent and Orally Well Absorbed Inhibitors of the VEGF Receptor Tyrosine Kinase Useful as Antagonists of Tumor-Driven angiogenesis” Journal of Medicinal Chemistry 2000, 43, 2310-2323.
40. Kumar, R.; Knick, V.B.; Rudolph, S.K. Pharmacokinetic-pharmacodynamic correlation from mouse to human with pazopanib, a multikinase
41. S. Schenone, F. Bondavalli, M. Botta, “Antiangiogenic agents: an update on small molecule VEGFR inhibitors”, Current Medicinal Chemistry, 2007, 14, 2495-2516.
42. G. Kesisis, H. Broxterman, G. Giaccone, Curr. Pharm. Des., 2007, 13, 2795-2809.
43. H. Zhong, J.P. Bowen, Curr. Top. Med. Chem., 2007, 7, 1379-1393.
44. A. Kiselyov, K.V. Balakin, S.E. Tkachenko, Expert Opin. Invest. Drugs, 2007, 16, 83-107.
45. G. Bold, K.H. Altmann, J. Frei, M. Lang, P.W. Manley, P. Traxler, B.
Wietfeld, J. Brüggen, E. Buchdunger, R. Cozens, S. Ferrari, , F. Hofmann, G. Martiny-Baron, J. Mestan, J. Rösel, M. Sills, D. Stover, F. Acemoglu, E.
Boss, R. Emmenegger, L. Lässer, E. Masso, R. Roth, C. Schlachter, W.
Vetterli, D. Wyss, J.M: Wood, Journal of Medicinal Chemistry, 2000, 43, 2310-2323.
46. P.W. Manley, P. Furet, G. Bold, J. Brüggen, J. Mestan, T. Meyer, C.R.
Schnell, J. Wood, M. Habery, A. Huth, M. Krüger, A. Menrad, E. Ottow, D.
Seidelmann, G. Siemeister, K.H. Thierauch, Journal of Medicinal Chemistry, 2002, 45, 5687-5693.
47. P.W. Manley, G. Bold, J. Brüggen, G.Fendrich, P. Furet, J. Mestan, C.
Schnell, B. Stolz, T. Meyer, B. Meyhack, W. Stark, A. Strauss, J. Wood, Biochim. Biophys. Acta Proteins Proteomics, 2004, 1697, 17-27.
48. Huse, M.; Kuriyan, J. Cell, 2002, 109, 275.
49. A. Papakyriakou, M.E. Katsarou, M. Belimezi, M. Karpusas, D.
Vourloumis, “Discovery of Potent Vascular Endothelial Growth Factor Receptor-2 Inhibitors”, ChemMedChem, 2010, 5, 118-129.
50. Bold, G.; Furet, P.; Manley, P.W. WO200452884, 2004.
51. Dumas, J.; Dixon, J.A. Exp. Opin. Ther. Patents, 2005, 15, 647.
52. Traxler, P.; Allegrini, P.R.; Brandt, B.; Brueggen, J.; Cozens, R.; Fabbro, D.; Grosios, K.; Lane, H.A.; McSheehy, P.; Mestan, J.; Meyer, T.; Tang, C.;
Wartmann, M.; Wood, J.; Caravatti, G. Cancer Res., 2004, 64, 4931.
53. Fraley, M.E.; Rubino, R.S.; Hoffmann, W.F.; Hambaugh, S.R.; Arrington, K.L.; Hungate, R.W.; Bilodeau, M.T.; Tebben, A.J.; Bilodeau, M.T.;
Tebben, A.J.; Rutledge, R.Z.; Kendall, R.L.; McFall, R.C.; Huckle, W.R.;
Coll, K.E.; Thomas, K.A. Bioorg. Med. Chem. Lett., 2002, 12, 3537.
54. Munchhof, M.J.; Beebe, J.S.; Casavant, J.M.; Cooper, B.A.; Doty. J.L.;
Higdon, R.C.; Hillermann, S.R.; Soderstrom, C.I.; Knauth, E.A.; Marx, M.A.; Rossi, A.M.; Sobolov, S.B.; Sun, J. Bioorg. Med. Chem. Lett., 2004, 14, 21.
55. Gangjee, A.; Zeng, Y.; Ihnat, M.; Warnke, L.A.; Green, D.W.; Kisliuk, R.L.;
Lin, F. Bioorg. Med. Chem., 2005, 13, 5475.
56. McDermott, L.A.; Simcox, M.; Higgins, B.; Nevins, T.; Kolinsky, K.;
Smith, M.; Yang, H. Li, J.K.; Chen, Y.; Ke, J.; Mallalieu, N.; Egan, T.;
Kolis, S.; Railkar, A.; Gerber, L.; Luk, K.C. Bioorg. Med. Chem., 2005, 13, 4835.
57. McDermott, L.A.; Higgins, B.; Simcox, M.; Luk, K.C.; Nevins, T.;
Kolinsky, K.; Smith, M.; Yang, H.; Li, J.K.; Chen, Y.; Ke, J.; Mallalieu, N.;
Egan, T.; Kolis, S.; Railkar, A.; Gerber, L.; Liu, J.J.; Konzelmann, F.;
Zhang, Z.; Flynn, T.; Morales, O.; Chen, Y. Bioorg. Med. Chem. Lett., 2006, 16, 1950.
58. Guo, X.N.; Zhong, L.; Tan, J.Z.; Li, J.; Luo, X.M.; Jiang, H.L.; Nan, F.J.;
Lin, L.P.; Zhang, X.W.; Ding, J. Cancer Biol. Ther., 2005, 4, 1125.
59. Huang, S.; Li, R.; Connolly, P.J.; Xu, G.; Gaul, M.D.; Emanuel, S.L.;
Lamontagne, K.R.; Greenberger, L.M. Bioorg. Med. Chem. Lett., 2006, 16, 6063.
60. Manley, P.J.; Balitza, A.E.; Bilodeau, M.T.; Coll, K.E.; Hartman, G.D.;
McFall, R.C.; Rickert, K.W.; Rodman, L.D.; Thomas, K.A. Bioorg. Med.
Chem. Lett., 2003, 13, 1673.
61. Emanuel, S.; Gruninger, R.H.; Fuentes-Pesquera, A.; Connolly, P.J.;
Seamon, J.A.; Hazel, S.; Tominovich, R.; Hollister, B.; Napier, C.;
D'Andrea, M.R.; Reuman, M.; Bignan, G.; Tuman, R.; Johnson, D.; Moffatt, D.; Batchelor, M.; Foley, A.; O'Connell, J.; Allen, R.; Perry, M.; Jolliffe, L.;
Middleton, S.A. Mol. Pharmacol., 2004, 66, 635.
62. Da Settimo, A.; Marini, A. M.; Primofiore, G.; Da Settimo, F.; Salerno, S.;
Viola, G.; Dalla Via, L.; Marciani Magno, S. Eur. J. Med. Chem. 1998, 33, 685.
63. Da Settimo, A.; Marini, A. M.; Primofiore, G.; Da Settimo, F.; Salerno, S.;
Dalla Via, L.; Gia, O.; Marciani Magno, S. Farmaco 2001, 56, 159.
64. Dalla Via, L.; Gia, O.; Marciani Magno, S.; Da Settimo, A.; Primofiore, G.;
Da Settimo, F.; Simorini, F.; Marini, A. M. Eur. J. Med. Chem. 2002, 37, 475.
65. Dalla Via, L.; Marini, A. M.; Salerno, S.; Toninello, A. Biochem.
Pharmacol. 2006, 72, 1657.
66. Marini, A. M.; Da Settimo, F.; Salerno, S.; La Motta, C.; Simorini, F.;
Taliani, S.; Bertini, D.; Gia, O.; Dalla Via, L. J. Heterocycl. Chem. 2008, 45, 745.
67. Dalla Via, L.; Gia, O.; Marciani Magno, S.; Marini, A.M.; Salerno, S.; Da Settimo, F.; Fornaciari, G.; Simorini, F.; La Motta, C.; Taiani, S.;
“Synthesis, Antiproliferative Activity And VEGFR-2 Inhibition of New Anilino-Substituted Thiopyrano Fused Pyrimidines”, XX National meeting on Medicinal Chemistry, September 12-16 2010 Abano Terme-Padova.
68. Gangjee, A.; Namjoshi O.A.; Yu, J.; Inhat, M.A.; Thorpe, J.E.; Warnke, L.A. Bioorg. Med. Chem. 2008, 16, 5514-5528.
69. Degani, I.; Fochi, R.; Spunta, G. Heteroaromatic cations. VI. Synthesis of thiachromylium perchlorate derivatives. Bollettino Scientifico della Facolta di Chimica Industriale di Bologna. 1966, 24, 75-91.
70. Eiden, F.; Schmiz, E. Studies on pyrones and pyridones. 76.
Dihydrobenzothiopyrano[4,3-b][1,5]benzodiazepin-7-ones and - benzodiazepinium salts. Archiv der Pharmazie. 1978, 311, 867-873.
71. Marini, Anna Maria; Da Settimo, Federico; Salerno, Silvia; La Motta, Concettina; Simorini, Francesca; Taliani, Sabrina; Bertini, Daniele; Gia, Ornella; Dalla Via, Lisa. Synthesis and in vitro antiproliferative activity of new substituted benzo[3',2':5,6]thiopyrano[4,3-d]pyrimidines. Journal of Heterocyclic Chemistry, 2008, 45(3), 745-749
72. Chu, S-L, Chyan, W-H, Chang, C-C. Inst. Of Med. Sci., Shangai, The preparation of the derivatives of 3-dialkylaminomethylthiachroman-4-ones.
Huaxue Xuebao. 1956, 22, 371-378
73. Primofiore, G.; Marini, A.M.; Da Settimo, F.; Salerno, S.; Bertini, D.; Dalla Via, L.; Marciani Magno, S.; J. Heterocyclic Chem, 2003, 40, 783-788.
74. Bruno, Olga; Schenone, Silvia; Ranise, Angelo; Bondavalli, Francesco;
Filippelli, Walter; Falcone, Giuseppe; Motola, Giulia; Mazzeo, Filomena.
Antiinflammatory agents: new series of N-substituted amino acids with complex pyrimidine structures endowed with antiphlogistic activity.
Farmaco, 1999, 54(1-2), 95-100.
75. Yifeng, L.; Yajun, B.; Juan, Z.; Yangyang, L.; Junping, J.; Xiaoli, Q.;
“Optimization of the Conditions for Copper-Mediated N-Arylation of Heteroarylamines”, Eur. J. Org. Chem., 2007, 6084-6088.
76. Da Settimo, A.; Marini, A.M.; Primofiore, G.; Da Settimo, F.; Salerno, S.;
La Motta, C.; Pardi, G.; Ferrarini, P.L.; Mori, C.; J. Heterocyclic Chem, 2000, 37, 379-382.
77. Crowther, A.F.; Curd, F.H.S.; Richardson, D.N.; Rose, F.L.; J. Chem. Soc., 1948, 1636-1645.
78. Bruno, Olga; Schenone, Silvia; Ranise, Angelo; Bondavalli, Francesco;
Barocelli, Elisabetta; Ballabeni, Vigilio; Chiavarini, Milena; Bertoni, Simona; Tognolini, Massimiliano; Impicciatore, Mariannina. New polycyclic pyrimidine derivatives with antiplatelet in vitro activity: synthesis and pharmacological screening. Bioorganic & Medicinal Chemistry, 2001, 9, 629-636.
79. Coxon, Ge. D.; Furman, B. L.; Harvey, A. L.; McTavish, J.; Mooney, M. H.;
Arastoo, M.; Kennedy, A. R.; Tettey, J. M.; Waigh, R.r D. Benzylguanidines and Other Galegine Analogues Inducing Weight Loss in Mice. Journal of Medicinal Chemistry, 2009, 52, 3457-3463.
80. Zimon, R.; Zejc, A. Synthesis of 2-benzylaminotetrahydropyrimidine-4,6- dione derivatives. Acta Poloniae Pharmaceutica, 1980, 37, 415-18.
